Latest Manufacturing News

Micro-X has secured an eight-month, US$0.75 million contract extension from the US Department of Homeland Security to upgrade its miniature CT baggage scanner for scaled manufacturing. The award advances a technology platform towards possible commercial use, but does not yet represent a product sale or customer deployment.

Synlait’s operational recovery gathered pace in the second half, but the NZX-listed dairy processor still reported a NZ$75.4 million FY26 loss and negative operating cash flow. KPMG flagged a material uncertainty over going concern as the company prepares to refinance facilities due in 2027.

Australian Vanadium reported progress across its mine, electrolyte and battery businesses, but auditors highlighted material uncertainty over the company’s ability to continue as a going concern. The group held $17.9 million in cash at 30 June, yet expects to need additional funding within 12 months.

First Graphene expanded its product range and international footprint in FY2026, lifting revenue while narrowing its annual loss. But the company says continued operations depend on securing further equity funding, putting commercial execution and liquidity at the centre of its next phase.

GCM Corporation’s FY26 report charts its shift from explorer to thermal-management manufacturer, with independent VHD validation, 44 products and first reported product sales. But the company remains loss-making, cash-burning and dependent on further funding, while its auditor warns of material uncertainty over going concern.

Prairie Lithium has moved its Saskatchewan project closer to commissioning, with Pad #1 construction advancing and Hydro Lithium agreeing to buy all Phase 1 output. The progress came alongside a A$3.46 million FY2026 loss, further equity issuance and a year-end cash balance of A$5.85 million.

Bremworth has restored internal yarn production, cut costs and improved its inventory profile, but FY26 still ended with an NZ$11.4 million loss. The company now enters FY27 under new ownership and board dynamics, with positive operating cash flow still to be achieved.

Nexsen has proposed a 50:50 joint venture with FlashDx Shenzhen to develop and commercialise an enhanced molecular Group B Streptococcus test, using an existing CE-marked platform as its starting point. The proposed venture could shorten Nexsen’s path into hospital and intrapartum testing across Asia-Pacific, but the term sheet remains non-binding and regulatory work is still ahead.

PPK Group has converted the sale of its Craig International Ballistics stake into a substantially stronger balance sheet, reporting a $19.2 million FY2026 profit and $27.7 million in cash. The challenge now is turning that one-off windfall into a durable operating business without overpaying or losing patience.

Big River Industries delivered a stronger FY26 despite subdued residential construction, lifting underlying EBITDA 8.4% and reducing gearing after its Johns Building Supplies acquisition. The company is targeting double-digit underlying EBITDA growth in FY27, while its strategic options review remains unresolved.

Adisyn has moved closer to commercialising its graphene platform after independently verified sub-300°C deposition, a US patent allowance and a new defence technology arm. The progress came alongside a A$7.83 million statutory loss, A$4.47 million in operating cash outflows and a heavily judgement-based A$42.1 million technology asset.

Immuron delivered record FY26 sales, a narrower loss and a much stronger cash balance, while shifting clinical development towards commercial partners. The annual report also flags a material weakness in inventory controls and confirms that IMM-529 remains dependent on a future licensing deal.